Table 2.
Functional site | Location* | References |
---|---|---|
Caspase-6 cleavage | IVLD 586 | Wellington et al., 2000 |
Caspase-2/3 cleavage | DLND 552 | Hermel et al., 2004 |
Caspase-3 cleavage | DVSD 513 | Wellington et al., 2000 |
Palmitoylation | C214 | Yanai et al., 2006 |
Phosphorylation | S421 | Warby et al., 2005 |
Calpain cleavage | VLS 438 | Gafni and Ellerby, 2002 |
SSS 537 | ||
Aspartyl protease cleavage | HCLT…NIVA 104–114 | Lunkes et al., 2002 |
RMVA…LLPC 146–214 | ||
Sumoylation, ubiquitylation | K6, K9, R15 | Steffan et al., 2004 |
Proteasome-targeting sequences | FQKLL 127 | Chandra et al., 2008 |
Nuclear export signal | IIIS…RLPL 2397–2406† | Xia et al., 2003 |
Putative nuclear localisation signal | PIRR…KEKE 1182–1191 | Bessert et al., 1995 |
Membrane-associated domain/cytoplasmic retention signal | MATL…LKSF 1–17 | Steffan et al., 2004; Truant et al., 2006 |
Motif sequence and position of the last residue in the motif in human HTT NP_002102, or sequence range for motifs >6 residues.
The nuclear export signal has two conservative Ile to Val changes between the human and mouse.